Gilead, Merus Strike Deal to Develop Novel Trispecific T-Cell Antibodies for Cancer Treatment

Agreement to focus on research, option, and licensing for discovery of dual tumor-associated antigen-targeting antibodies.

Source link
#Gilead #Merus #Strike #Deal #Develop #Trispecific #TCell #Antibodies #Cancer #Treatment